Study of clinical usefulness of an antiandrogen, TZP-4238, as a drug for treatment of benign prostatic hypertrophy--its influence on sexual function

Study of clinical usefulness of an antiandrogen, TZP-4238, as a drug for treatment of benign prostatic hypertrophy--its influence on sexual function

Using chlormadinone acetate (CMA) as the control drug, a double-blind study was carried out to examine not only the effects of 17 alpha-acetoxy-6-chloro-2-oxa-4,6-pregnadiene-3,20-dione (TZP-4238;) on subjective urinary symptoms but also, especially, that on the sexual function in patients with beni...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 40(1994), 8 vom: 01. Aug., Seite 745-59
1. Verfasser: Kumamoto, Y (VerfasserIn)
Weitere Verfasser: Tsukamoto, T, Aoki, M, Sato, Y, Umehara, T, Yoshida, O, Arai, Y, Kubo, T, Aoki, H, Komatsu, Y
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1994
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial Journal Article Multicenter Study Randomized Controlled Trial Androgen Antagonists Chlormadinone Acetate 0SY050L61N osaterone acetate FR26FSV5EZ